Diamond Hill Capital Comments on GlaxoSmithKline PLC

Author's Avatar
Jun 26, 2014

Global pharmaceutical company GlaxoSmithKline PLC (GSK) has several attractive franchises and pipeline drug candidates that have the potential to add significant value.

From Diamond Hill Capital's Select Fund Commentary – First Quarter 2014.